Sponsor:
Charlie Wang, MD, PhD
Code:
NCT06014905
Conditions
Meningioma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Hyperpolarized carbon C 13 pyruvate
Magnetic Resonance Image (MRI)
Saline
Brief summary:
Conditions
Meningioma
Study ID
NCT06014905
Start date
Sep 1, 2023
Status verified date
Aug, 2026
Completion date
Sep 30, 2027
Anticipated
Primary completion date
Sep 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: Hyperpolarized 13C pyruvate, Magnetic Resonance Imaging
Interventions
Hyperpolarized carbon C 13 pyruvate
Magnetic Resonance Image (MRI)
Saline
Primary outcome measure
Central contacts
Locations
University of California, San Francisco
Recruiting
San Francisco, California, United States, 94143
Contacts
Principal Investigator:
Charlie Wang, MD, PhD
Sponsor
Charlie Wang, MD, PhD
Last update posted
Aug 14, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Charlie Wang, MD, PhD on 2026-08-14.